Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 173 | 939 | 375 | 56 | 3 |
| TOTAL | $402 | $1,202 | $375 | $301 | $227 |
| Non-Current Assets | |||||
| PPE Net | 189 | 210 | 237 | 268 | 302 |
| Other Non-Current Assets | 486 | 460 | 374 | 237 | 237 |
| TOTAL | $675 | $670 | $611 | $504 | $539 |
| Total Assets | $1,077 | $1,872 | $986 | $805 | $765 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,499 | 2,351 | 1,418 | 330 | N/A |
| Accounts payable and accrued liabilities | 1,851 | 1,615 | 1,998 | 2,176 | 1,916 |
| Accrued Expenses | 884 | 384 | 464 | 602 | 318 |
| Other current liabilities | 1,033 | 4,799 | 1,782 | 127 | 299 |
| TOTAL | $7,267 | $9,149 | $5,662 | $3,235 | $2,532 |
| Non-Current Liabilities | |||||
| TOTAL | $96 | $96 | $96 | $96 | $96 |
| Total Liabilities | $7,363 | $9,245 | $5,758 | $3,331 | $2,628 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,004 | 11,538 | 11,402 | 11,125 | 11,127 |
| Common Shares | 116 | 115 | 114 | 111 | 111 |
| Retained earnings | -154,898 | -155,692 | -152,751 | -150,130 | -148,854 |
| Other shareholders' equity | 80 | 80 | 80 | 80 | -221 |
| TOTAL | $-6,286 | $-7,374 | $-4,772 | $-2,526 | $-1,862 |
| Total Liabilities And Equity | $1,077 | $1,872 | $986 | $805 | $765 |